Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: Implications for Alzheimer disease-related pathology

BMC Neuroscience

Volumn 8, Issue , 2007, Pages

  Cao, Xia ^a   Wei, Zelan ^a   Gabriel, Geraldine G ^a   Li, XinMin ^a   Mousseau, Darrell D ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMYLOID BETA PROTEIN; CALBINDIN; CALCIMYCIN; CALCIUM ION; PEROXY RADICAL; AMINE OXIDASE (FLAVIN CONTAINING); CALCIUM; FREE RADICAL; PEROXIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME MECHANISM; FETUS; GENE OVEREXPRESSION; HIPPOCAMPUS; MOUSE; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; CELL LINE; COMPARATIVE STUDY; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; ANIMALS; CALCIUM; CELL LINE, TRANSFORMED; CELLS, CULTURED; FREE RADICALS; HIPPOCAMPUS; MICE; MONOAMINE OXIDASE; OXIDATIVE STRESS; PEROXIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 35648950425     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-8-73     Document Type: Article

References (67)

1. Sies H Strategies of antioxidant defense European journal of biochemistry/FEBS 1993, 215(2):213-219. 10.1111/ j.1432-1033.1993.tb18025.x 7688300
2. Zhu Y Carvey PM Ling Z Age-related changes in glutathione and glutathione-related enzymes in rat brain Brain research 2006, 1090(1):35-44. 1868496 16647047 10.1016/j.brainres.2006.03.063
3. Crack PJ Cimdins K Ali U Hertzog PJ Iannello RC Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons J Neural Transm 2006, 113(5):645-657. 10.1007/s00702-005-0352-y 16252075
4. Youdim MB Edmondson D Tipton KF The therapeutic potential of monoamine oxidase inhibitors Nature reviews 2006, 7(4):295-309. 10.1038/nrn1883 16552415
5. Magyar K Palfi M Tabi T Kalasz H Szende B Szoko E Pharmacological aspects of (-)-deprenyl Current medicinal chemistry 2004, 11(15):2017-2031. 15279565
6. Magyar K Szende B (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties Neurotoxicology 2004, 25(1-2):233-242. 10.1016/S0161-813X(03)00102-5 14697898
7. Riederer P Lachenmayer L Laux G Clinical applications of MAO-inhibitors Current medicinal chemistry 2004, 11(15):2033-2043. 15279566
8. Saura J Luque JM Cesura AM Da Prada M Chan-Palay V Huber G Loffler J Richards JG Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography Neuroscience 1994, 62(1):15-30. 10.1016/ 0306-4522(94)90311-5 7816197
9. McLellan ME Kajdasz ST Hyman BT Bacskai BJ In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy J Neurosci 2003, 23(6):2212-2217. 12657680
10. Shih JC Chen K Ridd MJ Monoamine oxidase: From genes to behavior Annual review of neuroscience 1999, 22:197-217. 10.1146/annurev.neuro.22.1.197 10202537
11. Brunner HG Nelen M Breakefield XO Ropers HH van Oost BA Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A Science (New York, NY 1993, 262(5133):578-580.
12. Caspi A McClay J Moffitt TE Mill J Martin J Craig IW Taylor A Poulton R Role of genotype in the cycle of violence in maltreated children Science (New York, NY 2002, 297(5582):851-854.
13. Meyer JH Ginovart N Boovariwala A Sagrati S Hussey D Garcia A Young T Praschak-Rieder N Wilson AA Houle S Elevated monoamine oxidase a levels in the brain: An explanation for the monoamine imbalance of major depression Archives of general psychiatry 2006, 63(11):1209-1216. 10.1001/archpsyc.63.11.1209 17088501
14. Thorpe L Groulx B Depressive syndromes in dementia The Canadian journal of neurological sciences 2001, 28 Suppl 1:S83-95. 11237316
15. Nishimura AL Guindalini C Oliveira JR Nitrini R Bahia VS de Brito-Marques PR Otto PA Zatz M Monoamine oxidase a polymorphism in Brazilian patients: Risk factor for late-onset Alzheimer's disease? J Mol Neurosci 2005, 27(2):213-217. 10.1385/JMN:27:2:213 16186632
16. Wu CK Mesulam MM Geula C Age-related loss of calbindin from human basal forebrain cholinergic neurons Neuroreport 1997, 8(9-10):2209-2213. 9243613
17. Emilsson L Saetre P Balciuniene J Castensson A Cairns N Jazin EE Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients Neuroscience letters 2002, 326(1):56-60. 10.1016/S0304-3940(02)00307-5 12052537
18. Takehashi M Tanaka S Masliah E Ueda K Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant Neuroscience letters 2002, 327(2):79-82. 10.1016/S0304-3940(02)00258-6 12098640
19. Amrein R Martin JR Cameron AM Moclobemide in patients with dementia and depression Advances in neurology 1999, 80:509-519. 10410765
20. Gareri P Falconi U De Fazio P De Sarro G Conventional and new antidepressant drugs in the elderly Progress in neurobiology 2000, 61(4):353-396. 10.1016/S0301-0082(99)00050-7 10727780
21. Rosenzweig P Patat A Zieleniuk I Cimarosti I Allain H Gandon JM Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor Clinical pharmacology and therapeutics 1998, 64(2):211-222.
22. Malorni W Giammarioli AM Matarrese P Pietrangeli P Agostinelli E Ciaccio A Grassilli E Mondovi B Protection against apoptosis by monoamine oxidase A inhibitors FEBS letters 1998, 426(1):155-159. 10.1016/ S0014-5793(98)00315-9 9598998
23. Maher P Davis JB The role of monoamine metabolism in oxidative glutamate toxicity J Neurosci 1996, 16(20):6394-6401. 8815918
24. Maragos WF Young KL Altman CS Pocernich CB Drake J Butterfield DA Seif I Holschneider DP Chen K Shih JC Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice Neurochemical research 2004, 29(4):741-746. 10.1023/B:NERE.0000018845.82808.45 15098936
25. Ou XM Chen K Shih JC Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway Proceedings of the National Academy of Sciences of the United States of America 2006, 103(29):10923-10928. 1544150 16829576 10.1073/pnas.0601515103
26. Ward MW Kushnareva Y Greenwood S Connolly CN Cellular and subcellular calcium accumulation during glutamate-induced injury in cerebellar granule neurons Journal of neurochemistry 2005, 92(5):1081-1090. 10.1111/ j.1471-4159.2004.02928.x 15715659
27. Rao VL Nitric oxide in hepatic encephalopathy and hyperammonemia Neurochemistry international 2002, 41(2-3):161-170. 10.1016/ S0197-0186(02)00038-4 12020616
28. Mousseau DD Baker GB Butterworth RF Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy Journal of neurochemistry 1997, 68(3):1200-1208. 9048767
29. Egashira T Sakai K Sakurai M Takayama F Calcium disodium edetate enhances type A monoamine oxidase activity in monkey brain Biological trace element research 2003, 94(3):203-211. 10.1385/BTER:94:3:203 12972688
30. Samantaray S Chandra G Mohanakumar KP Calcium channel agonist, (+/-)-Bay K8644, causes a transient increase in striatal monoamine oxidase activity in Balb/c mice Neuroscience letters 2003, 342(1-2):73-76. 10.1016/S0304-3940(03)00238-6 12727321
31. Kosenko EA Venediktova NI Kaminskii Iu G [Calcium and ammonia stimulate monoamine oxidase A activity in brain mitochondria] Izvestiia Akademii nauk 2003, 542-546.
32. Kabuto H Yokoi I Mori A Murakami M Sawada S Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine Mechanisms of ageing and development 1995, 80(1):1-9. 10.1016/0047-6374(94)01542-T
33. Zatta P Nicosia V Zambenedetti P Evaluation of MAO activities on murine neuroblastoma cells upon acute or chronic treatment with aluminium (III) or tacrine Neurochemistry international 1998, 32(3):273-279. 10.1016/ S0197-0186(97)00095-8 9587921
34. Bu J Sathyendra V Nagykery N Geula C Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex Experimental neurology 2003, 182(1):220-231. 10.1016/S0014-4886(03)00094-3 12821392
35. Geula C Nagykery N Wu CK Bu J Loss of calbindin-D28K from aging human cholinergic basal forebrain: Relation to plaques and tangles Journal of neuropathology and experimental neurology 2003, 62(6):605-616.
36. Kirischuk S Pronchuk N Verkhratsky A Measurements of intracellular calcium in sensory neurons of adult and old rats Neuroscience 1992, 50(4):947-951. 10.1016/0306-4522(92)90217-P 1448206
37. Holt A Baker GB Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine Naunyn-Schmiedeberg's archives of pharmacology 1996, 354(1):17-24. 10.1007/BF00168701 8832583
38. Shih JC Molecular basis of human MAO A and B Neuropsychopharmacology 1991 4 (1):1-7. 2003865
39. Jenner P Olanow CW Oxidative stress and the pathogenesis of Parkinson's disease Neurology 1996, 47(6 Suppl 3):S161-70. 8959985
40. Kennedy BP Ziegler MG Alford M Hansen LA Thal LJ Masliah E Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease J Neural Transm 2003, 110(7):789-801. 12811639
41. Sherif F Gottfries CG Alafuzoff I Oreland L Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease Journal of neural transmission 1992, 4(3):227-240. 10.1007/BF02260906 1627256
42. Altura BM Calcium antagonist properties of magnesium: Implications for antimigraine actions Magnesium 1985, 4(4):169-175. 3908832
43. Montero M Alonso MT Carnicero E Cuchillo-Ibanez I Albillos A Garcia AG Garcia-Sancho J Alvarez J Chromaffin-cell stimulation triggers fast millimolar mitochondrial Ca2+ transients that modulate secretion Nature cell biology 2000, 2(2):57-61. 10.1038/35000001 10655583
44. Rizzuto R Pozzan T Microdomains of intracellular Ca2+: Molecular determinants and functional consequences Physiological reviews 2006, 86(1):369-408. 10.1152/physrev.00004.2005 16371601
45. Robb-Gaspers LD Burnett P Rutter GA Denton RM Rizzuto R Thomas AP Integrating cytosolic calcium signals into mitochondrial metabolic responses The EMBO journal 1998, 17(17):4987-5000. 1170827 9724635 10.1093/emboj/17.17.4987
46. White RJ Reynolds IJ Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurones The Journal of physiology 1997 498(Pt 1):31-47. 1159232 9023766
47. Herrington J Park YB Babcock DF Hille B Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells Neuron 1996, 16(1):219-228. 10.1016/S0896-6273(00)80038-0 8562086
48. Xu T Naraghi M Kang H Neher E Kinetic studies of Ca2+ binding and Ca2+ clearance in the cytosol of adrenal chromaffin cells Biophysical journal 1997, 73(1):532-545. 1180952 9199815
49. Duchen MR Contributions of mitochondria to animal physiology: From homeostatic sensor to calcium signalling and cell death The Journal of physiology 1999, 516(Pt 1):1-17. 10.1111/j.1469-7793.1999.001aa.x 10066918
50. Baimbridge KG Celio MR Rogers JH Calcium-binding proteins in the nervous system Trends in neurosciences 1992, 15(8):303-308. 10.1016/ 0166-2236(92)90081-I 1384200
51. Wu CK Nagykery N Hersh LB Scinto LF Geula C Selective age-related loss of calbindin-D28k from basal forebrain cholinergic neurons in the common marmoset (Callithrix jacchus) Neuroscience 2003, 120(1):249-259. 10.1016/ S0306-4522(03)00248-3 12849757
52. Palop JJ Jones B Kekonius L Chin J Yu GQ Raber J Masliah E Mucke L Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits Proceedings of the National Academy of Sciences of the United States of America 2003, 100(16):9572-9577. 170959 12881482 10.1073/pnas.1133381100
53. Thibault O Porter NM Chen KC Blalock EM Kaminker PG Clodfelter GV Brewer LD Landfield PW Calcium dysregulation in neuronal aging and Alzheimer's disease: History and new directions Cell calcium 1998, 24(5-6):417-433. 10.1016/S0143-4160(98)90064-1 10091010
54. Chan-Palay V Hochli M Savaskan E Hungerecker G Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease Dementia (Basel, Switzerland) 1993, 4(1):1-15. 10.1159/000107290 8358501
55. Yenari MA Minami M Sun GH Meier TJ Kunis DM McLaughlin JR Ho DY Sapolsky RM Steinberg GK Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia Stroke; a journal of cerebral circulation 2001, 32(4):1028-1035. 11283407
56. Phillips RG Meier TJ Giuli LC McLaughlin JR Ho DY Sapolsky RM Calbindin D28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults Journal of neurochemistry 1999, 73(3):1200-1205. 10.1046/j.1471-4159.1999.0731200.x 10461912
57. Wernyj RP Mattson MP Christakos S Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide Brain research 1999, 64(1):69-79. 10.1016/S0169-328X(98)00307-6 9889325
58. Mattson MP Rychlik B Chu C Christakos S Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons Neuron 1991, 6(1):41-51. 10.1016/0896-6273(91)90120-O 1670921
59. Brorson JR Bindokas VP Iwama T Marcuccilli CJ Chisholm JC Miller RJ The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation Journal of neurobiology 1995, 26(3):325-338. 10.1002/neu.480260305 7775966
60. Quevedo J Vianna M Daroit D Born AG Kuyven CR Roesler R Quillfeldt JA L-type voltage-dependent calcium channel blocker nifedipine enhances memory retention when infused into the hippocampus Neurobiology of learning and memory 1998, 69(3):320-325. 10.1006/nlme.1998.3822
61. Heidrich A Rosler M Riederer P [Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies] Fortschritte der Neurologie-Psychiatrie 1997, 65(3):108-121. 9173033
62. Yamada M Itoh Y Suematsu N Otomo E Matsushita M Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain Annals of neurology 1996, 40(2):243-245. 10.1002/ana.410400217 8773607
63. Yew DT Chan WY Early appearance of acetylcholinergic, serotoninergic, and peptidergic neurons and fibers in the developing human central nervous system Microscopy research and technique 1999, 45(6):389-400. 10.1002/(SICI)1097-0029(19990615)45:6<389::AID-JEMT6>3.0.CO;2-Z
64. Smith IF Green KN LaFerla FM Calcium dysregulation in Alzheimer's disease: Recent advances gained from genetically modified animals Cell calcium 2005, 38(3-4):427-437. 10.1016/j.ceca.2005.06.021 16125228
65. Supnet C Grant J Kong H Westaway D Mayne M Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice The Journal of biological chemistry 2006, 281(50):38440-38447. 10.1074/ jbc.M606736200 17050533
66. Burke WJ Li SW Chung HD Ruggiero DA Kristal BS Johnson EM Lampe P Kumar VB Franko M Williams EA Zahm DS Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases Neurotoxicology 2004, 25(1-2):101-115. 10.1016/S0161-813X(03)00090-1 14697885
67. Liu Y Piasecki D A cell-based method for the detection of nanomolar concentrations of bioactive amyloid Analytical biochemistry 2001, 289(2):130-136. 10.1006/abio.2000.4928 11161306